A carregar...
721. In Vitro Activity of Cefiderocol Against Gram-Negative Clinical Isolates From New York City
BACKGROUND: Multidrug-resistant Gram-negative bacteria have become a serious problem in hospitals worldwide. Cefiderocol (CFDC) is a novel siderophore cephalosporin with activity against a wide range of carbapenemase- and ESBL-producing bacteria. We tested the activity of CFDC against (1) a recent c...
Na minha lista:
| Publicado no: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811323/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.789 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|